To determine if plasma circulating HPV DNA (cHPVDNA) has potential as a non-invasive biomarker for identification and treatment monitoring of cervical intraepithelial neoplasia grades 2-3 by characterizing correlation between plasma cHPVDNA levels and cervical intraepithelial neoplasia grade prior to intervention and after excision.
You will be asked for a cervical swab, DNA testing, blood draws and urine samples. If you undergo treatment for an abnormal area on the cervix, you may be asked for a second blood draw.
$30, Gift Card for participation
Lineberger Comprehensive Cancer Center
NC Cancer Hospital (Basnight)
UNC Hospitals / UNC Medical Center
101 Manning Dr, Chapel Hill, NC 27514, USA
Shivani Sud
Radiation Oncology - Chapel Hill
Clinical or Medical
Interventional
Cancer (Cervical)
Immune System/Infections
Sexual and/or Reproductive Health
Women's Health
19-2196
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
